Journal of Liver Cancer

Search: J Liver Cancer Search

CLOSE

Review Article

March 31, 2019

Recent Advances and Future Directions in Immunotherapeutics for Hepatocellular Carcinoma

Yuri Cho, Jimin Han, Won Kim

J Korean Liver Cancer Stud. 2019;19(1):1-11.

Systemic target therapeutic drugs, such as sorafenib, lenvatinib, or regorafenib are the only drugs that are known to be effective against advanced hepatocellular carcinoma (HCC). However, these agents show a...

Review Article

March 31, 2019

Clinical Application of Liver Stiffness Measurement for Assessing the Risk of Hepatocellular Carcinoma

Jeong-Ju Yoo, Eun-Ae Jung, Sang Gyune Kim

J Korean Liver Cancer Stud. 2019;19(1):12-18.

The most significant risk factor for hepatocellular carcinoma (HCC) is the presence of cirrhosis or advanced fibrosis of the liver. Liver biopsy was traditionally considered the gold standard for assessing...

Review Article

March 31, 2019

Conventional Chemoembolization for Hepatocellular Carcinoma: Role of Cone-Beam Computed Tomography Guidance

In Joon Lee, Jin Wook Chung

J Korean Liver Cancer Stud. 2019;19(1):19-29.

Conventional chemoembolization using Lipiodol-based regimens was introduced in the 1980s, and it is currently recommended as the primary treatment modality for patients with unresectable, intermediate, or locally advanced hepatocellular carcinoma...

Original Article

March 31, 2019

Discrepancy between the Actual Clinical Status of Patients with Hepatocellular Carcinoma and Expectations from Hepatocellular Carcinoma Surveillance: a Single-Center Study

Nak Min Kim, Young Seok Doh, Ji Woong Jang, et al.

J Korean Liver Cancer Stud. 2019;19(1):30-37.

Background/Aims: The National Liver Cancer Screening Program (NLCSP) has been implemented for the past 15 years in Korea. However, the actual clinical experience in Korea is inconsistent with the expectations...

Original Article

March 31, 2019

High-dose versus Low-dose 5-Fluorouracil and Cisplatin Based Hepatic Arterial Infusion Chemotherapy for Advanced Hepatocellular Carcinoma

Chae-June Lim, Ji-Yun Hong, Yang-Seok Ko, et al.

J Korean Liver Cancer Stud. 2019;19(1):38-45.

Backgrounds/Aims: Hepatic arterial infusion chemotherapy (HAIC) has been reported as an effective treatment for advanced hepatocellular carcinoma. The aim of this study is to compare the effect and safety between...

Original Article

March 31, 2019

Effect of PTEN Polymorphism on the Development of Hepatitis B Virus-associated Hepatocellular Carcinoma

Soon Sun Kim, Jung Woo Eun, Hyo Jung Cho, et al.

J Korean Liver Cancer Stud. 2019;19(1):46-54.

Background/Aims: Phosphatase and tensin homolog (PTEN) is a known tumor suppressor gene that is downregulated in hepatocellular carcinoma (HCC). Here, we investigated the association between single nucleotide polymorphisms (SNPs) of...

Current Issue: Volume 19(1); Mar 2019

This archive contains links to the full-text of all issues of J Liver Cancer.

Current issue

Volume 19(1); March

All issues

Vol. 19
2019

v.19(1)
Mar 2019

Vol. 18
2018

v.18(1)
Mar 2018

v.18(2)
Sep 2018

Vol. 17
2017

v.17(1)
Mar 2017

v.17(2)
Sep 2017

Vol. 16
2016

v.16(1)
Mar 2016

v.16(2)
Sep 2016

Vol. 15
2015

v.15(1)
Mar 2015

v.15(2)
Sep 2015

Journal of the Korean Liver Cancer Study2001 (v1 n1) to 2014 (v14 n2)

Vol. 14
2014

v.14(1)
Mar 2014

v.14(2)
Sep 2014

Vol. 13
2013

v.13(1)
Feb 2013

v.13(2)
Sep 2013

Vol. 12
2012

v.12(1)
Feb 2012

v.12(2)
Sep 2012

Vol. 11
2011

v.11(1)
Feb 2011

v.11(2)
Sep 2011

Vol. 10
2010

v.10(1)
Jun 2010

Vol. 9
2009

v.9(1)
Jun 2009

Vol. 8
2008

v.8(1)
Jun 2008

Vol. 7
2007

v.7(1)
Jun 2007

Vol. 6
2006

v.6(1)
Jun 2006

Vol. 5
2005

v.5(1)
Jun 2005

Vol. 4
2004

v.4(1)
Jun 2004

Vol. 3
2003

v.3(1)
Jul 2003

Vol. 2
2002

v.2(1)
Jul 2002

Vol. 1
2001

v.1(1)
Jun 2001

Editorial Office: 1527 Gangnam Finance Plaza (FASTFIVE), 419 Teheran-ro, Gangnam-gu, Seoul 06160, Korea
Tel: +82-2-313-1900 E-mail: liver@klcsg.or.kr

Copyright © 2019 by The Korean Liver Cancer Association. All rights reserved.

prev

next

prev

next